{"url":"https://lda.senate.gov/api/v1/filings/c8b6f765-0d64-4542-89e2-2b64075e6dbf/","filing_uuid":"c8b6f765-0d64-4542-89e2-2b64075e6dbf","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2010,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/c8b6f765-0d64-4542-89e2-2b64075e6dbf/print/","filing_document_content_type":"text/html","income":"70000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Robert Driscoll, Partner","dt_posted":"2010-07-20T20:10:01.577000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"THE ATLANTIC BUILDING","registrant_address_2":"950 F STREET, NW","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":1182,"url":"https://lda.senate.gov/api/v1/registrants/1182/","house_registrant_id":31748,"name":"ALSTON & BIRD LLP","description":"Law Firm","address_1":"THE ATLANTIC BUILDING","address_2":"950 F STREET, NW","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ADAM J. BIEGEL","contact_telephone":"+1 202-239-3692","dt_updated":"2026-07-20T16:02:02.800694-04:00"},"client":{"id":102415,"url":"https://lda.senate.gov/api/v1/clients/102415/","client_id":1005573,"name":"SCHILTZ FOODS, INC.","general_description":"Goose farm specializing in developing goose antibodies; producer of geese & geese products","client_government_entity":false,"client_self_select":false,"state":"SD","state_display":"South Dakota","country":"US","country_display":"United States of America","ppb_state":"SD","ppb_state_display":"South Dakota","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-09-09"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Funding for H1N1 antibody development; FY11 appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":50795,"prefix":"ms","prefix_display":"MS.","first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"LANGOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48702,"prefix":"mr","prefix_display":"MR.","first_name":"JEFFREY","nickname":null,"middle_name":"R","last_name":"SURAL","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}